Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Biomarker Validation for Genomic Assays
Assay Developers Put Their Tests to the Test and Demonstrate the Clinical Utility of Genomic Biomarkers
For full access to this article login to GEN Select now.
BioMarket Trends: Process Improvements Bolster Peptide Drug Market
Stability, Cost, Delivery, and Manufacturing Challenges Are Being Worked Out
- An analysis of launched peptide drugs and compounds in late-stage development indicated that the peptide market would grow in 2006 at a rate of approximately 5%. Beginning in late 2007, Phase III and some fast-track Phase II candidates will start moving through the registration and approval process. As these ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.